Symbol="ADIL"
AssetType="Common Stock"
Name="Adial Pharmaceuticals Inc"
Description="Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapies for the treatment or prevention of addictions and related disorders. The company is headquartered in Charlottesville, Virginia."
CIK="1513525"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="1180 SEMINOLE TRAIL, SUITE 495, CHARLOTTESVILLE, VA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="131745000"
EBITDA="-13170611"
PERatio="None"
PEGRatio="None"
BookValue="1.262"
DividendPerShare="0"
DividendYield="0"
EPS="-0.49"
RevenuePerShareTTM="0"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.922"
ReturnOnEquityTTM="-2.096"
RevenueTTM="0"
GrossProfitTTM="0"
DilutedEPSTTM="-0.49"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="150"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="-"
PriceToBookRatio="1.179"
EVToRevenue="-"
EVToEBITDA="-0.0585"
Beta="0.938"
num_52WeekHigh="15.25"
num_52WeekLow="4.37"
num_50DayMovingAverage="6.32"
num_200DayMovingAverage="7.74"
SharesOutstanding="29942000"
DividendDate="None"
ExDividendDate="None"
symbol="ADIL"
open="4.75"
high="6.16"
low="4.37"
price="4.40"
volume="932841.00"
latest_trading_day="2023-08-11"
previous_close="4.78"
change="-0.38"
change_percent="-7.9498%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="67"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="33"
Volume_recent_avg="1630161"
Change_recent_avg="-0.01"
Delta_recent_avg="0.09"
Variance_recent_avg="0.05"
Change_ratio_recent_avg="-0.91"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="33"
Aroon_momentum_negative="67"
image_negative_thumbnail_id_1="114"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0062.jpeg"
image_negative_thumbnail_id_2="96"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0080.jpeg"
image_neutral_thumbnail_id_1="578"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0021.jpeg"
image_neutral_thumbnail_id_2="552"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0047.jpeg"
image_positive_thumbnail_id_1="624"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0084.jpeg"
image_positive_thumbnail_id_2="669"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0039.jpeg"
image_professor_thumbnail_id_1="1199"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0033.jpeg"
image_professor_thumbnail_id_2="1185"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0019.jpeg"
